Superdisintegrants Market report is a comprehensive overview of the market’s situation thoroughly examined and compiled by Stratview Research. This new report provides past progress, current market conditions, and a future prospect from the year 2022 to 2028. It also offers accurate overview of the growth strategies, market size, mergers acquisitions, and upcoming products/services of leading key players in this market.
Market Insights
The report analyses the market thoroughly and collects data in order to offer reliable data to the users. The present report mentions that the Superdisintegrants Market is projected to grow from USD 387.13 million in 2021 to USD 653.99 million by 2028 at a CAGR of around 7.72% during the forecast period of 2022-2028.
The growth of superdisintegrants market is primarily driven by the increasing use of orally disintegrating tablets. Expanding geriatric populace and rising prevalence of chronic diseases are likely to bolster the growth of the superdisintegrants market at a significant rate during the review period. In addition to this, a growing focus on RD activities for new drug development is likely to create lucrative opportunities for the players operating in the global market in the coming years.
Market Segments' Analysis
According to Stratview Research, the Superdisintegrants Market is segmented By Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins, Other), Formulation (Tablet, Capsules), Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases), and Region.
By formulation, the superdisintegrants market has been bifurcated into tablets and capsules. The tablet segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the increasing consumption of orally disintegrating tablets across the geographies.
By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to increasing investment in RD activities for the development of new drugs coupled with expanding geriatric populace and the presence of key market players such as FMC Corporation (US) and Ashland Global Specialty Chemicals Inc. (US). The market growth in Asia-Pacific is expected to be driven by increasing spending on healthcare coupled with rising health consciousness and rising per capita disposable income of the consumers.
Top key vendors in the market:
The report mentions a list of key players in the Superdisintegrants Market. Some of them are mentioned below –
- Ashland Global Specialty Chemicals Inc. (US)
- BASF SE (Germany)
- FMC Corporation (US)
- JRS Pharma (Germany)
- DFE Pharma (Germany)
- Roquette (France)
- Dow (US)
- Asahi Kasei Corporation (Japan)
- Nippon Soda (Japan)
- M. Huber Corporation (US)
Before investing, get a free sample report here : https://www.stratviewresearch.com/Request-Sample/2477/Superdisintegrants-Market.html#form
About Us –
Stratview Research is a global market research firm offering analytics, research, and advisory that can assist the clients to renovate their business and modify the approach. The reports offered can help the users in taking decisions intrepidly. Along with the reports, Stratview Research also offers customization services. In order to customize any of the report, please connect with our team.
Stratview Research
Call Us: +1-313-307-4176
Mail Us: [email protected]
